Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: Hydroxychloroquine in Treating Patients With Rising PSA Levels After Local Therapy for Prostate Cancer [Phase 2]
Phase 2 clinical trial update evaluating hydroxychloroquine in patients with rising PSA after local therapy for prostate cancer has complete…
-
CLINICAL_TRIALS trial_result · 2022-06-13Clinical Trial Update: A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer [Phase 2]
Phase 2 trial comparing 177Lu-PSMA617 theranostic therapy to cabazitaxel in progressive metastatic castration-resistant prostate cancer has …
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Volatile Anaesthesia and Perioperative Outcomes Related to Cancer Feasibility Study [Phase 4]
Phase 4 clinical trial update on volatile anesthesia and perioperative outcomes in cancer patients; study completed.
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: Prostate Cancer Detection Screening MRI Protocol [NA]
Clinical trial update for a prostate cancer detection screening MRI protocol; study completed with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer [Phase 3]
Phase 3 trial comparing hypofractionated versus conventional radiation therapy after prostate cancer surgery; study completed with results p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-05-25Clinical Trial Update: Durvalumab and Tremelimumab in Treating Chemotherapy Naive Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 study of durvalumab and tremelimumab in chemotherapy-naive metastatic castration-resistant prostate cancer has completed; results we…
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: Radiotherapy Plus Hormone Therapy in Biochemically-relapsing Prostate Cancer Patients Following Surgery [Phase 1, Phase 2]
Clinical trial update evaluating radiotherapy plus hormone therapy in biochemically-relapsing prostate adenocarcinoma after radical prostate…
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: Testosterone and Olaparib in Treating Patients With Castration-Resistant Prostate Cancer [Phase 2]
A Phase 2 trial evaluating the combination of testosterone and olaparib in castration-resistant prostate cancer has completed, with results …
-
CLINICAL_TRIALS trial_result · 2022-05-18Clinical Trial Update: A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer [NA]
Phase II prospective study evaluating MRI reclassification for men considering active surveillance in prostate cancer; study completed with …
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Efavirenz in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 trial investigating efavirenz for metastatic prostate cancer has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2022-05-16Clinical Trial Update: Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced Malignancies [Phase 1, Phase 2]
Phase 1/2 trial evaluating isatuximab plus cemiplimab in advanced malignancies (prostate cancer and non-small cell lung cancer) has terminat…
-
CLINICAL_TRIALS trial_result · 2022-05-12Clinical Trial Update: Trial Evaluating the Safety of 2 Schedules of Cabazitaxel in Elderly Men With mCRPC Previously Treated With a Docetaxel [Phase 3]
Phase 3 trial evaluating two cabazitaxel dosing schedules in elderly men with metastatic prostate cancer previously treated with docetaxel h…
-
CLINICAL_TRIALS trial_result · 2022-05-11Clinical Trial Update: Prostate Cancer Monitoring Using [18F]DCFPyL and Blood Based Biomarkers [Phase 2]
Phase 2 clinical trial update evaluating monitoring of metastatic prostate cancer using [18F]DCFPyL PET imaging and blood-based biomarkers.
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: Culture-guided Antimicrobial Prophylaxis in Men Undergoing Prostate Biopsy. [Phase 4]
Phase 4 trial update on culture-guided antimicrobial prophylaxis in men undergoing prostate biopsy, focusing on infection-related outcomes a…
-
CLINICAL_TRIALS trial_result · 2022-05-05Clinical Trial Update: Open Label Phase I/Randomised,Double Blind Phase II Study in mCRPC of AZD5363 In Combination With DP Chemotherapy [Phase 1, Phase 2]
Open-label Phase I/Randomized, Double-Blind Phase II study evaluating AZD5363 in combination with DP chemotherapy for metastatic castration-…
-
CLINICAL_TRIALS trial_result · 2022-05-02Clinical Trial Update: Biodistribution and Dosimetry of Ga-68 P16-093 in Prostate Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial update evaluating the biodistribution and dosimetry of Ga-68 P16-093 in prostate cancer (recurrent and broader pr…
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: Enzalutamide Versus Standard Androgen Deprivation Therapy for the Treatment Hormone Sensitive Prostate Cancer [Phase 2]
Phase 2 trial comparing enzalutamide to standard androgen deprivation therapy in hormone-sensitive prostate cancer has completed and posted …
-
CLINICAL_TRIALS trial_result · 2022-04-27Clinical Trial Update: sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]
Phase 2 clinical trial update for sEphB4-HSA in metastatic castration-resistant prostate cancer; status not clearly specified and results po…
-
CLINICAL_TRIALS trial_result · 2022-04-22Clinical Trial Update: Hyperpolarized C-13 Pyruvate as a Biomarker in Patients With Advanced Solid Tumor Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating hyperpolarized C-13 pyruvate as a biomarker in advanced solid tumor malignancies, with prostate cance…
-
CLINICAL_TRIALS trial_result · 2022-04-15Clinical Trial Update: Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel [Phase 2, Phase 3]
A completed Phase 2/3 trial update evaluating the optimal sequencing of treatments for poor-risk metastatic castration-resistant prostate ca…
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: PET/CT and WB MRI for Staging and Response in CRPC Patients Receiving Enzalutamide [Phase 2]
Phase 2 clinical trial evaluating PET/CT and WB MRI for staging and response in metastatic prostate cancer patients receiving enzalutamide h…
-
CLINICAL_TRIALS trial_result · 2022-04-14Clinical Trial Update: Imaging Staging and Response Prediction in Metastatic Hormono-Sensitive Prostate Cancer Patients Receiving Enzalutamide [Phase 2]
Phase 2 trial update exploring imaging staging and response prediction in metastatic hormone-sensitive prostate cancer patients treated with…
-
CLINICAL_TRIALS trial_result · 2022-04-06Clinical Trial Update: Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating hormone therapy in combination with intensity-modulated radiation therapy for metastatic prostate cancer, with resu…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Maintaining Suppression of Testosterone With Transdermal Estradiol Gel [Phase 2]
Phase 2 trial update on maintaining suppression of testosterone with transdermal estradiol gel in prostate cancer; study terminated with pos…
-
CLINICAL_TRIALS trial_result · 2022-03-31Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual. [Phase 4]
A Phase 4 clinical trial evaluating switching from Zoladex monthly or quarterly to Eligard semiannual in men with prostate cancer has comple…